Agreement expands Piramal’s payload-linker platform and bioconjugate abilities.

Eli Lilly and Company has announced plans to invest more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Puerto Rico.

Ajinomoto Co., Inc. has signed a licensing agreement with Astellas Pharma Inc. for the use of AJICAP—an antibody-drug conjugate (ADC) development and manufacturing technology—as part of its CDMO ...

Thermo Fisher Scientific Inc. has agreed to acquire Clario Holdings Inc., a provider of digital endpoint data solutions for clinical trials, in a cash transaction valued at $8.875 billion.

The Pistoia Alliance, a global, not-for-profit alliance, is launching Phase 3 of its Chemistry, Manufacturing and Controls (CMC) Process Ontology project.

Apeloa Pharmaceutical, a global provider of technology-driven pharmaceutical manufacturing solutions, has passed its 20th U.S. FDA inspection.

Wheeler Bio has partnered with Mitsubishi Corporation to expand its commercial reach and business development activities across the Asia-Pacific region.

Will transfer commercial manufacturing for a leading injectable pharmaceutical product from the current manufacturer to Lifecore’s facilities.

The certification highlights the company’s adherence to rigorous safety and traceability protocols within the cell and gene therapy supply chain.

Ajinomoto Bio-Pharma Services and Olon S.p.A. have entered into a strategic partnership to deliver drug substance manufacturing services.

Catalent has introduced a new corporate brand, signaling a strategic shift aimed at enhancing customer service and reinforcing its role in global healthcare.

Lifecore Biomedical, Inc., a an integrated CDMO, and PolyPeptide Laboratories, Inc ., a global peptide contract development and manufacturer, entered a collaboration agreement aimed at providing an ...